MedPath

Diagnostic accuracy of intracranial lesion using 11C-Methionine PET/CT

Not Applicable
Conditions
Brain tumor
Registration Number
JPRN-UMIN000042984
Lead Sponsor
Rehabilitation Center for Traumatic Apallics Chiba
Brief Summary

Based on the ROC analyses, the cutoffs were 3.33 for maximum SUV, 2.54 for mean SUV, 2.33 for peak SUV, 2.04 for Lmax/Nmean, and 2.23 for Lmax/Nmax. The sensitivity and specificity of these cutoffs were 69.2% and 82.6%, respectively, for maximum SUV, 64.1% and 91.3% for mean SUV, 69.2% and 91.3% for peak SUV, 70.5% and 91.3% for Lmax/Nmax and 75.6% and 82.6% for Lmax/Nmean.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
425
Inclusion Criteria

Not provided

Exclusion Criteria

1.Subjects who have no final clinical diagnosis. 2.Subjects who cannot provide informed consent.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Final diagnosis
Secondary Outcome Measures
NameTimeMethod
Maximum diameter, Shape, Lesion/normal ratio, Number, Area
© Copyright 2025. All Rights Reserved by MedPath